Olanzapine pamoate: a stick in time?
暂无分享,去创建一个
[1] L. Hranov,et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial , 2008, The Lancet.
[2] P. Weiden,et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. , 2004, Psychiatric services.
[3] M. Valenstein,et al. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. , 2006, The Journal of clinical psychiatry.
[4] M. Byerly,et al. Antipsychotic medication adherence in schizophrenia. , 2007, The Psychiatric clinics of North America.
[5] J. Lieberman,et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.
[6] L. Citrome,et al. Compelling or irrelevant? Using number needed to treat can help decide , 2008, Acta psychiatrica Scandinavica.
[7] J. Lauriello,et al. An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. , 2008, The Journal of clinical psychiatry.
[8] I. Glick,et al. A meta-analysis of the efficacy of second-generation antipsychotics , 2003, Schizophrenia Research.
[9] L. Citrome,et al. Olanzapine: review of safety 2008 , 2008 .
[10] S. Soumerai,et al. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. , 2008, The Journal of clinical psychiatry.
[11] Leslie Citrome,et al. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks , 2008, Expert review of neurotherapeutics.
[12] S. Kapur,et al. D2 Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia , 2008, Neuropsychopharmacology.
[13] G. Morken,et al. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia , 2008, BMC psychiatry.
[14] L. Citrome,et al. Do guidelines for severe mental illness promote physical health and well-being? , 2005, Journal of psychopharmacology.